- Home
- Science
- Life Sciences
- Omics Technologies in Cancer Biomarker Discovery
Omics Technologies in Cancer Biomarker Discovery
List Price:
$52.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Xuewu Zhang
Format:
Hardcover
Pages:
150
Publisher:
CRC Press (March 10, 2011)
Language:
English
ISBN-13:
9781587063398
Weight:
10.375oz
Dimensions:
6" x 9"
File:
TAYLORFRANCIS-TayFran_260513043821732-20260513.xml
Folder:
TAYLORFRANCIS
List Price:
$52.99
Country of Origin:
United States
Case Pack:
55
As low as:
$50.34
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Imprint:
CRC Press
Overview
The early detection of human cancer is still one of the great challenges in the battle against this disease. Single biomarkers are not likely to provide sufficient diagnostic power and multibiomarker assays should be developed in order to reach high diagnostic accuracy for cancer screening at the population level. Omics technologies are emerging new biomarker discovery tools and have a high potential to yield panels of novel and cancer-specific biomarkers. This book provides an overview of recent studies aimed at the discovery of new cancer biomarkers through omics-based approaches, including genomics, transcriptomics, proteomics, metabonomics, peptidomics, phosphoproteomics, immunomics, glycoproteomics, lipidomics, bioinformatics and integrative omics technologies. The book serves as an introduction to researchers in the field and provides the platforms to facilitate the development of new approaches in cancer research.








